BR0008709A - Método para diagnosticar diferencialmente emonitorar carcinomas malignos de mama - Google Patents

Método para diagnosticar diferencialmente emonitorar carcinomas malignos de mama

Info

Publication number
BR0008709A
BR0008709A BR0008709-2A BR0008709A BR0008709A BR 0008709 A BR0008709 A BR 0008709A BR 0008709 A BR0008709 A BR 0008709A BR 0008709 A BR0008709 A BR 0008709A
Authority
BR
Brazil
Prior art keywords
women
levels
cancer
breast
breast cancer
Prior art date
Application number
BR0008709-2A
Other languages
English (en)
Inventor
Charles F Streckfus
Lenora G Bigler
James Tate Thigpen
Original Assignee
Univ Mississipi Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mississipi Medical Ct filed Critical Univ Mississipi Medical Ct
Publication of BR0008709A publication Critical patent/BR0008709A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"MéTODO PARA DIAGNOSTICAR DIFERENCIALMENTE EMONITORAR CARCINOMAS MALIGNOS DE MAMA". Um painelde biomarcadores para o diagnóstico e tratamento de câncer demama foi examinado na saliva de uma amostragem de 1) mulheressaudáveis, 2) mulheres com lesões benignas de mama e 3)mulheres com câncer de mama diagnosticado. Reconhecidosmarcadores de tumor c-erbB-2 (erb), antígeno de câncer 15-3 (CA15-3), e proteína 53 oncogênica supressora de tumor (p53) foramencontrados na saliva de todos os três grupos de mulheres. Osníveis de erb e CA 15-3 nos pacientes com câncer avaliados,contudo, eram significativamente mais altos do que os níveissalivares dos controles saudáveis e dos pacientes com tumorbenigno. Por outro lado, os níveis de pantrópico p53 eram maisaltos nos controles em comparação àquelas mulheres com câncerde mama e aquelas com tumores benignos.
BR0008709-2A 1999-03-01 2000-03-01 Método para diagnosticar diferencialmente emonitorar carcinomas malignos de mama BR0008709A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/259,993 US6294349B1 (en) 1999-03-01 1999-03-01 Method of diagnosing and monitoring malignant breast carcinomas
PCT/US2000/005364 WO2000052463A1 (en) 1999-03-01 2000-03-01 Method of diagnosing and monitoring malignant breast carcinomas

Publications (1)

Publication Number Publication Date
BR0008709A true BR0008709A (pt) 2001-12-18

Family

ID=22987369

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008709-2A BR0008709A (pt) 1999-03-01 2000-03-01 Método para diagnosticar diferencialmente emonitorar carcinomas malignos de mama

Country Status (11)

Country Link
US (3) US6294349B1 (pt)
EP (1) EP1161680A4 (pt)
JP (1) JP2002538462A (pt)
CN (1) CN1349611A (pt)
AU (1) AU3613400A (pt)
BR (1) BR0008709A (pt)
CA (1) CA2363566A1 (pt)
HK (1) HK1044816A1 (pt)
MX (1) MXPA01008794A (pt)
NO (1) NO20014223L (pt)
WO (1) WO2000052463A1 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294349B1 (en) 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
WO2004029575A2 (en) * 2002-05-17 2004-04-08 Eastern Virginia Medical School Methods for diagnosing htlv-i-mediated diseases
US20040033613A1 (en) * 2002-05-30 2004-02-19 Zwick Michael G. Saliva-based protein profiling
EP1651095A4 (en) * 2003-08-05 2008-10-08 Euro Celtique Sa ErbB RECEPTOR PROCESS AND SETS FOR MONITORING CHEMOTHERAPY RESISTANCE
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050106642A1 (en) * 2003-11-19 2005-05-19 Lipps Binie V. Saliva test for early diagnosis of cancers
US20050186215A1 (en) * 2004-02-04 2005-08-25 Kwok Tim T. CUDR as biomarker for cancer progression and therapeutic response
EP1730304B1 (en) * 2004-02-20 2013-01-02 The Regents of the University of California Methods for salivary mrna profiling.
US7964408B1 (en) 2004-05-13 2011-06-21 University Of South Florida Lysophospholipids as biomarkers of ovarian cancer
EP1761648A1 (en) * 2004-06-18 2007-03-14 Roche Diagnostics GmbH Use of protein pdx1 as a marker for breast cancer
US20060115827A1 (en) * 2004-07-01 2006-06-01 University Of Southern California Genetic markers for predicting disease and treatment outcome
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
MX2007003003A (es) * 2004-09-17 2007-11-09 Univ Johns Hopkins Biomarcadores para cancer de mama.
WO2007086915A2 (en) * 2005-05-12 2007-08-02 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
EP1934373A4 (en) * 2005-09-14 2009-04-29 Univ California SAVER PROTEIN AND RNA FOR THE DETECTION OF BREAST CANCER
KR100828539B1 (ko) * 2005-09-20 2008-05-13 후지제롯쿠스 가부시끼가이샤 이차원 코드의 검출 방법, 검출 장치, 및 검출 프로그램을기억한 기억 매체
WO2007048107A2 (en) * 2005-10-19 2007-04-26 Heska Corporation Proteomic profiling of mast cell tumors and related methods, proteins and nucleic acid molecules
EP2177910A1 (en) * 2005-11-10 2010-04-21 Aurelium Biopharma Inc. Tissue diagnostics for breast cancer
US8722349B2 (en) 2006-04-03 2014-05-13 Oratel Diagnostics, Llc Methods and kit for endometriosis screening
CA2655997A1 (en) * 2006-06-30 2008-01-10 Schering Corporation Igfbp2 biomarker
WO2008088343A1 (en) * 2007-01-19 2008-07-24 Biophysical Corporation Methods for individualized health assessment service
WO2008124525A1 (en) * 2007-04-03 2008-10-16 Vanderbilt University Nanoparticles with molecular recognition elements
EP2201363A4 (en) * 2007-09-18 2011-03-16 Univ Texas DETECTION IN SALIVA OF MODULATED PROTEINS PRODUCED FOLLOWING CANCER CARCINOMA IN SITU BREAST
CN101234026B (zh) * 2008-03-07 2010-04-14 李立 一种乳腺病变定量化影像评价系统
WO2011133770A2 (en) * 2010-04-21 2011-10-27 Board Of Regents Of The University Of Texas System Salivary protein markers for detection of breast cancer
EP2606144B1 (en) 2010-08-20 2016-06-15 Oratel Diagnostics, LLC Estrous cycle monitoring by color response
EP3384939A1 (en) 2011-03-11 2018-10-10 Vib Vzw Molecules and methods for inhibition and detection of proteins
US8841130B2 (en) 2011-07-11 2014-09-23 Oratel Diagnostics, Llc Methods and kit for endometriosis diagnosis
CN104067126B (zh) 2011-11-15 2017-04-12 迈阿密大学 用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法
CN104142397A (zh) * 2014-08-06 2014-11-12 厦门大学 胸腺素alpha原在制备乳腺癌诊断标记物中的应用
WO2016130543A1 (en) * 2015-02-09 2016-08-18 Abogen, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis
JP2017211886A (ja) * 2016-05-26 2017-11-30 株式会社ブラケアジェネティクス 女性の健康増進に有用なカスタマイズ情報の提供システム
JP2020511933A (ja) * 2016-11-22 2020-04-23 プライム ゲノミクス，インク． 癌検出のための方法
JP2020521452A (ja) 2017-05-24 2020-07-27 パンディオン・セラピューティクス・インコーポレイテッド 標的化免疫寛容
KR102018171B1 (ko) * 2017-10-16 2019-09-04 헨리기술 주식회사 타액을 이용한 유방암 감지 키트 및 이를 이용한 유방암 감지 방법
CN111247432A (zh) * 2017-10-16 2020-06-05 亨利技术有限公司 使用唾液的乳腺癌检测试剂盒及乳腺癌检测方法以及使用唾液的可孕期检测试剂盒及可孕期检测方法
US10174092B1 (en) 2017-12-06 2019-01-08 Pandion Therapeutics, Inc. IL-2 muteins
US10946068B2 (en) 2017-12-06 2021-03-16 Pandion Operations, Inc. IL-2 muteins and uses thereof
US11078256B2 (en) 2018-06-26 2021-08-03 The Board Of Regents Of The University Of Texas System Methods and compositions for inhibiting cancer cell growth
JP2022533702A (ja) 2019-05-20 2022-07-25 パンディオン・オペレーションズ・インコーポレイテッド ＭＡｄＣＡＭ標的化免疫寛容
CN110297082A (zh) * 2019-06-12 2019-10-01 杭州启创生物技术有限公司 唾液尿酸等标志物特异性检测和诊断痛风的方法
US11981715B2 (en) 2020-02-21 2024-05-14 Pandion Operations, Inc. Tissue targeted immunotolerance with a CD39 effector

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401638A (en) 1986-06-04 1995-03-28 Oncogene Science, Inc. Detection and quantification of neu related proteins in the biological fluids of humans
US5512657A (en) 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
US5527676A (en) * 1989-03-29 1996-06-18 The Johns Hopkins University Detection of loss of the wild-type P53 gene and kits therefor
DE69033842T2 (de) * 1989-08-04 2002-06-20 Schering Ag Äusserliche domäne von c-erbb-2:gp75
JP3971454B2 (ja) 1993-10-29 2007-09-05 ザ トラスティーズ オブ ボストン ユニバーシティ 抗新生物剤としての酪酸、酪酸塩、および誘導体の生理学的に安定な組成物
AU1837495A (en) * 1994-10-13 1996-05-06 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
US5840889A (en) 1996-04-19 1998-11-24 The Board Of Regents Of The University Of Nebraska Synthesis of estrogen-purine base and estrogen-mercapturate adducts and development of fluorescent probes and monoclonal antibodies to assay those adducts
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
US7393823B1 (en) * 1999-01-20 2008-07-01 Oregon Health And Science University HER-2 binding antagonists
US6294349B1 (en) * 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas

Also Published As

Publication number Publication date
US6294349B1 (en) 2001-09-25
US6670141B2 (en) 2003-12-30
CN1349611A (zh) 2002-05-15
EP1161680A1 (en) 2001-12-12
NO20014223L (no) 2001-10-23
CA2363566A1 (en) 2000-09-08
AU3613400A (en) 2000-09-21
WO2000052463A9 (en) 2002-04-11
EP1161680A4 (en) 2002-04-17
NO20014223D0 (no) 2001-08-31
HK1044816A1 (zh) 2002-11-01
US6972180B1 (en) 2005-12-06
JP2002538462A (ja) 2002-11-12
US20020015964A1 (en) 2002-02-07
WO2000052463A1 (en) 2000-09-08
MXPA01008794A (es) 2003-07-28

Similar Documents

Publication Publication Date Title
BR0008709A (pt) Método para diagnosticar diferencialmente emonitorar carcinomas malignos de mama
Dahlstrom et al. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions
Dresner et al. Pattern of recurrence following radical oesophagectomy with two‐field lymphadenectomy
Sakr et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients
Omar et al. Breast cancer in Egypt: a review of disease presentation and detection strategies
Lestón et al. Diagnostic clinical aids in oral cancer
Dahlstrom et al. Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme
ATE125626T1 (de) Cytokeratin-tumormarkierer und test zu deren nachweis.
Matsunaga et al. Intraductal biopsy for diagnosis and treatment of intraductal lesions of the breast
Ames et al. Radiolocalization of the sentinel lymph node in Merkel cell carcinoma: a clinical analysis of seven cases
Kubota et al. Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature
Hermann et al. Results of conservative operations for breast cancer
McGee et al. The value of axillary dissection in T1a breast cancer
Lam et al. Early diagnosis of lung cancer
Yamaguchi et al. Intraductal papillary-mucinous tumor of the pancreas: assessing the grade of malignancy from natural history
Whitworth et al. State-of-the-art lymph node staging for breast cancer in the year 2000
Mori et al. Clinicopathologic studies of gastric carcinoma
Ringenberg Tumors of unknown origin
Farrand et al. Epidermoid carcinoma of the breast
Reintgen et al. The Role of Selective Lymphadenectomy in Breast Cancer: Lymphatic mapping and sentinel node biopsy allow full nodal staging information with a minimally invasive procedure.
Choong et al. Size and tinning of local recurrence predicts metastasis in soft tissue sarcoma Growth rate index retrospectively analyzed in 134 patients
Jang et al. Detection of pre-invasive endobronchial tumors with D-light/autofluorescence system
Chagpar et al. Can tumor biology predict occult multifocal disease in breast cancer patients?
Deliveliotis et al. The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view
Graves et al. Surgery for early and minimally invasive breast cancer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.